Valcyte (valganciclovir) - Roche, Mitsubishi Tanabe
Prevymis (letermovir) - Merck (MSD)
FURTHER EVIDENCE SUPPORTING THE USE OF LETERMOVIR FOR CMV PROPHYLAXIS - IT'S NOT ONLY LEUKOPENIA. (PubMed, Am J Transplant) - Aug 26, 2025 - No abstract available 
Journal • Hematological Disorders • Leukopenia • Transplantation
http://www.ncbi.nlm.nih.gov/pubmed/40854486
 
Anders Åsberg; Ilkka Helanterä
 
Aug 26, 2025
 
Prev Next